X-Therma pioneers ground-breaking cold chain technology via a convergent biopreservation platform, to advance Regenerative Medicine and make available safe and on-demand organs, engineered tissues, cell & gene therapies, vaccines, and beyond. X-Therma’s technology makes worldwide organ sharing possible and eliminates organ waiting lists. The FDA has granted its proprietary organ preservation solution, XT-ViVo®, and TimeSeal® Organ Transport Device, Breakthrough Device status. X-Therma is headquartered in Richmond, San Francisco Bay Area, and has expanded to Austria in Europe